Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM)
HLSSM
Sayed Issa's Hybrid Limited Shoulder Surgical Management (HLSSM)
2 other identifiers
interventional
44
1 country
1
Brief Summary
Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM) is a limited lateral approach to the shoulder arthroscopically guided. Which achieves less surgical trauma and smaller surgical incision than even in Mini Lateral Shoulder Approach (MLSA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 9, 2023
CompletedJune 26, 2023
September 1, 2020
2.7 years
May 12, 2023
June 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Less open surgery trauma
Directly going to the goal lesion with less expansion
25 minutes to 45 minutes,
Secondary Outcomes (1)
Smaller surgical incision than MLSA
Less than 5 cm
Study Arms (1)
Issa3
EXPERIMENTALDr.A.Sayed Issa and his team
Interventions
Using Arthroscopy and then Limited Opening by Mini Lateral Shoulder Approach (MLSA) for the shoulder surgery.
Eligibility Criteria
You may qualify if:
- Patients presented with Shoulder Impingement Syndrome refractory to conservative treatment and local steroid injection
- Patients presented with Adhesive Capsulitis and Frozen Shoulder Syndrome refractory to conservative treatment and local steroid injection
- Patients without femur head immigration on X-ray
- Patients with injury for one month to six months maximum
You may not qualify if:
- Patients with femur head immigration on X-ray
- Patients with injury for more than six months
- Uncontrolled diabetes mellitus type 1 and 2
- Patients with non controlled Vascular hypertension
- Significant renal disease, defined as a history of chronic renal failure requiring dialysis or kidney transplant.
- Myocardial infarction, other acute cardiac event requiring hospitalization, stroke, transient ischemic attack, or treatment for acute congestive heart failure within 4 months prior to randomization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Abdulhamid Sayed Issa Clinic
Aleppo, Syria
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDIV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2023
First Posted
June 9, 2023
Study Start
September 1, 2020
Primary Completion
May 12, 2023
Study Completion
May 12, 2023
Last Updated
June 26, 2023
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will share